These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 23929238)

  • 21. [Evidence-based use of methotrexate in children with rheumatic disorders. Consensus statement of the Working Group for Children and Adolescents with Rheumatic Diseases in Germany (AGKJR) and the Working Group Pediatric Rheumatology Austria].
    Niehues T; Horneff G; Michels H; Sailer Höck M; Schuchmann L
    Z Rheumatol; 2004 Apr; 63(2):147-58. PubMed ID: 15112095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Role of the Institute of Rheumatology in formation and development of State controlling system of rheumatic diseases].
    Folomeeva OM; Amirdzhanova VN
    Vestn Ross Akad Med Nauk; 1998; (12):9-12. PubMed ID: 9987951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prognosis for rheumatoid arthritis].
    Ostendorf GM
    Versicherungsmedizin; 2015 Mar; 67(1):36. PubMed ID: 25971151
    [No Abstract]   [Full Text] [Related]  

  • 24. Implementation of recommended non-pharmacotherapy in rheumatology practice: need for improvement.
    van der Linden S; Boonen A; van Tubergen A; Vosse D; Dekker J; Dijkmans B; van der Horst-Bruinsma I; Kapinga T; van der Leeden M; van den Ende C; Hazes JM; Linssen A; Vliet Vlieland T
    Clin Exp Rheumatol; 2016; 34(1 Suppl 95):S15-7. PubMed ID: 26316176
    [No Abstract]   [Full Text] [Related]  

  • 25. Standardizing assessment of adverse effects in rheumatology clinical trials. Status of OMERACT Toxicity Working Group March 2000: towards a common understanding of comparative toxicity/safety profiles for antirheumatic therapies.
    Woodworth TG; Furst DE; Strand V; Kempeni J; Fenner H; Lau CS; Miller F; Day R; Lipani J; Brooks P
    J Rheumatol; 2001 May; 28(5):1163-9. PubMed ID: 11361207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Recommendations of the DGRh on the therapy of Raynaud Syndrome (Zeitschrift für Rheumatologie, vol 64, March 2005) ].
    Fiehn C
    Z Rheumatol; 2005 Sep; 64(6):429. PubMed ID: 16184353
    [No Abstract]   [Full Text] [Related]  

  • 27. Emerging issues in pharmacological management of rheumatoid arthritis: results of a national needs assessment survey identifying practice variations for the development of Canadian Rheumatology Association clinical practice recommendations.
    Bykerk VP; Schieir O; Akhavan P; Hazlewood GS; Cheng CK; Bombardier C
    J Rheumatol; 2012 Aug; 39(8):1555-8. PubMed ID: 21885494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Quality assurance in rheumatology].
    Keitel W
    Z Arztl Fortbild Qualitatssich; 1999 Mar; 93(2):141-4. PubMed ID: 10355064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The case against haste in the treatment of rheumatoid arthritis: comment on the editorial by Pincus et al.
    Epstein WV
    Arthritis Rheum; 2003 Feb; 48(2):573-5; author reply 576-9. PubMed ID: 12571870
    [No Abstract]   [Full Text] [Related]  

  • 30. EULAR recommendations for vaccination in paediatric patients with rheumatic diseases.
    Heijstek MW; Ott de Bruin LM; Bijl M; Borrow R; van der Klis F; Koné-Paut I; Fasth A; Minden K; Ravelli A; Abinun M; Pileggi GS; Borte M; Wulffraat NM;
    Ann Rheum Dis; 2011 Oct; 70(10):1704-12. PubMed ID: 21813547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treat to participation : Position paper of the German Society for Rheumatology on sustained improvement of functional health of patients with rheumatic and musculoskeletal diseases].
    Mau W; Beyer W; Ehlebracht-König I; Engel JM; Genth E; Lange U;
    Z Rheumatol; 2015 Aug; 74(6):553-7. PubMed ID: 26238709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Issues of consensus and debate for economic evaluation in rheumatology.
    Coyle D; Welch V; Shea B; Gabriel S; Drummond M; Tugwell P
    J Rheumatol; 2001 Mar; 28(3):642-7. PubMed ID: 11296975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of the British Society for Rheumatology Biologics Register (BSRBR) and the NICE guidelines for anti-TNF therapy.
    Watson K; Hyrich K
    Musculoskeletal Care; 2003 Mar; 1(1):58-64. PubMed ID: 20217664
    [No Abstract]   [Full Text] [Related]  

  • 34. [Comments by the German Society of Rheumatology (DGRh) to report on the plan for Biologicals in the second-line therapy of rheumatoid arthritis].
    Braun J; Krüger K; Genth E
    Z Rheumatol; 2011 Nov; 70(9):809-11. PubMed ID: 22086227
    [No Abstract]   [Full Text] [Related]  

  • 35. Rheumatologic rehabilitation: the great expectation for rheumatic patients.
    Maddali Bongi S; Matucci Cerinic M
    Reumatismo; 2012 Mar; 64(1):1-6. PubMed ID: 22472777
    [No Abstract]   [Full Text] [Related]  

  • 36. [Practical problems by implementation of vaccination recommendations].
    Fendler C; Saracbasi E; Dybowski F; Heldmann F; Braun J
    Z Rheumatol; 2012 Feb; 71(2):147-50, 153-5. PubMed ID: 22370806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccination in adults with autoimmune rheumatic diseases.
    Kwok TSH; Libman M; Lake SL
    CMAJ; 2019 Sep; 191(36):E1005. PubMed ID: 31501182
    [No Abstract]   [Full Text] [Related]  

  • 38. Optimisation of assessment for rheumatic diseases in clinical trials, observational studies and routine clinical care.
    Pincus T; Braun J; Kavanaugh A; Smolen JS
    Clin Exp Rheumatol; 2014; 32(5 Suppl 85):S-1. PubMed ID: 25365080
    [No Abstract]   [Full Text] [Related]  

  • 39. The situation of rheumatology today in Germany.
    Kaiser H
    Rev Rhum Engl Ed; 1998 Feb; 65(2):135-8. PubMed ID: 9540122
    [No Abstract]   [Full Text] [Related]  

  • 40. [Current status of methotrexate].
    Fiehn C
    Z Rheumatol; 2011 Feb; 70(2):99-100. PubMed ID: 21312022
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.